Ming Yin Lin
Papers
1
Total Citations
47
H-Index
1
About
Ming Yin Lin is a leading clinical researcher in gynecologic oncology, with a primary focus on improving surgical management and outcomes for women with endometrial cancer. Her most influential work centers on the role of sentinel lymph node biopsy as a less invasive alternative to systematic lymphadenectomy. She is the principal investigator of the landmark phase III randomized trial ENDO-3 (ANZGOG 1911/2020), which directly compares sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer. This study, published in 2021 and already cited 47 times, addresses a critical clinical question: whether omitting full nodal dissection can reduce morbidity without compromising oncologic safety. Dr. Lin’s contributions are shaping international guidelines and practice patterns, offering patients a more tailored, less morbid approach to staging. Her work exemplifies the shift toward precision surgery in gynecologic oncology, balancing diagnostic accuracy with quality of life. Through rigorous trial design and collaborative leadership within the Australia New Zealand Gynaecological Oncology Group (ANZGOG), she continues to influence evidence-based care for early-stage endometrial cancer.
Research Focus
Key Achievements
Top Papers
- 1